ASHERSON, RONALD AMD, FACP, FCP,(SA) 1; KHAMASHTA, MUNTHER AMD 1; ORDI-ROS,
JOSE MD 3; DERKSEN, RONALD HWMMD 2; MACHIN, SAMUEL JMD, FRC PATH. 4; …

The term ‘catastrophic’ antiphospholipid syndrome (APS) is used to define an accelerated
form of APS resulting in multiorgan failure. Although catastrophicAPS patients represent less …

… Asherson RA, Piette JC. The catastrophic antiphospholipid syndrome in 1996: Acute multi-organfailure
associated with antiphospholipid antibodies. A review of 31 patients. …

Quantitative isotype specific enzyme linked immunosorbent assay (ELISA) was used to
determine the distribution of immunoglobulin isotypes and phospholipid specificities of …

• To determine the predictive value of the IgG anticardiolipin antibody (ACA) test for
thrombosis, recurrent fetal loss, and thrombocytopenia, the clinical features of 121 patients with …

… Complement serum levels (C3, C4, and CH50) were normal and all serum tests for
rheumatoid arthritis and SLE including LA and VDRL were negative. A pharyngeal smear was …

… The “catastrophic” variant of the antiphospholipid syndrome (CAPS) was described by Asherson
in 1992 … In 2003, the eponym “Asherson's syndrome” was proposed for the condition (5). …

A prospective echocardiographic study was carried out on 132 consecutive patients with
systemic lupus erythematosus (SLE) derived from three European university medical centres. …

Many infections have been found to be associated with antiphospholipid antibodies (aPL),
although a pathogenic role for these antibodies has not usually been obvious except in a few …

… APS has increased over the past years, and it is now clear that it is not only associated with
SLE or primary APS, but also with other autoimmune conditions such as rheumatoid arthritis, …